PI3K-AKT signaling is one of the key pathways in the occurrence and development of HCC, and dysregulation of this signaling pathway can lead to reduced cell proliferation and apoptosis and inhibition of tumor development [30–32]. Here, AKT1 is linked to hepatocellular carcinoma.